Companion Diagnostics Market Size, Share, By Offerings (Products and Services), Technology (Polymerase Chain Reaction (PCR), Next-generation Sequencing (NGS), Immunohistochemistry (IHC), Fluorescence In Situ Hybridization (FISH), and, Others), Therapeutic Area (Oncology, Immunology, Neurology, Autoimmune, Cardiovascular, Infectious Disease, and Others), End-User (Pharmaceutical & Biotechnological Companies, Contract Research Laboratories, Diagnostics Laboratories, and Others), and Region - Trends, Analysis, and Forecast till 2035

Report Code: PMI49019 | Publish Date: April 2024 | No. of Pages: 187

Global Companion Diagnostics Market Market Companies

  • Foundation Medicine, Inc.
  • F. Hoffmann-La Roche Ltd
  • Agilent Technologies, Inc.
  • QIAGEN
  • Thermo Fisher Scientific Inc.
  • Abbott
  • Illumina, Inc
  • Myriad Genetics, Inc.
  • BIOMÉRIEUX
  • BioGenex
  • Guardant Health
  • Labcorp
  • Quest Diagnostics Incorporated
  • Sysmex Corporation

Recent News:

  • BD and Quest Diagnostics, announced a global collaboration on July 2024 to develop, manufacture and commercialize flow cytometry-based companion diagnostics, aimed to help patients with best treatment for cancer and other diseases. This collaboration aimed to provide the pharmaceutical industry with new solutions for companion diagnostics development and exploratory panel development to the manufacturing and distribution of FDA-approved diagnostic kits.

Companion Diagnostics Market Companies Forecast 2025-2035